Senior insider sale
PROTAGONIST THERAPEUTICS, INC — senior position signals high conviction
$2.52M
24K shares
What this filing means
SELICK HAROLD E plans to sell 24K shares of PROTAGONIST THERAPEUTICS, INC valued at approximately $2.52M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/26/2026ACC: 0001950047-26-003020
Director
Since Apr 2019
24K
Shares to sell
$2.52M
Approx. market value
24K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
3/26/2026
24KTotal acquired24K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/26/2026 | Stock Option Exercise Cash | 24K | — |
| Total | 24K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
24K
Market value
$2.52M
3/26/2026
Total
Units
24K
Value
$2.52M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
3/26/2026 | 24K | $2.52M | NASDAQ | Planned |
| Total | 24K | $2.52M | ||